Family offices of billionaires target healthcare and biotech startups
The investment arms of high-net-worth individuals, including Stanley Druckenmiller, are directing capital into early-stage healthcare and biotech ventures. Focus areas include gene editing and drug discovery, with activity reported in August.
Sources: msn.com
“This trend underscores how family offices—often more patient than traditional VCs—are filling gaps in deep-tech funding where long-term horizons deter conventional investors.”
Read the original reporting
The outlets below did the original reporting.
Related briefs
This brief was drafted automatically from the sources above and published under our editorial policy. Spotted an error? Tell us.